Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study

키워드

참고문헌 (54)

1. Headache Classification Committee of the International Headache Society (IHS), "The International Classification of Headache Disorders, 3rd edition (beta version)", Cephalalgia, 33, pp.629~808 (2013)
2. Marmura MJ, "The acute treatment of migraine in adults : the american headache society evidence assessment of migraine pharmacotherapies", Headache, 55, pp.3~20 (2015)
3. Prior MJ, "A randomized, placebocontrolled trial of acetaminophen for treatment of migraine headache", Headache, 50, pp.819~833 (2010)
4. Lipton RB, "Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebocontrolled, population-based study", Arch Intern Med, 160, pp.3486~3492 (2000)
5. Becker WJ, "Acute migraine treatment in adults", Headache, 55, pp.778~793 (2015)
6. Suthisisang C, "Efficacy of low-dose ibuprofen in acute migraine treatment : systematic review and meta-analysis", Ann Pharmacother, 41, pp.1782~1791 (2007)
7. Boska MD, "Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes", Neurology, 58, pp.1227~1233 (2002)
8. Mauskop A, "Serum ionized magnesium levels and serum ionized calcium", ionized magnesium ratios in women with menstrual migraine, 2002, pp.42, 242~248
9. Trauninger A, "Oral magnesium load test in patients with migraine", Headache, 42, pp.114~119 (2002)
10. Cete Y, "A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the emergency department", Cephalalgia, 25, pp.199~204 (2005)
11. Demirkaya S, "Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks", Headache, 41, pp.171~177 (2001)
12. Bigal ME, "Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study", Cephalalgia, 22, pp.345~353 (2002)
13. Corbo J, "Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache", Ann Emerg Med, 38, pp.621~627 (2001)
14. Köseoglu E, "The effects of magnesium prophylaxis in migraine without aura", Magnes Res, 21, pp.101~108 (2008)
15. Teigen L, "An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine", Cephalalgia, 35, pp.912~922 (2015)
16. Baratloo A, "The role of caffeine in pain management: a brief literature review", Anesth Pain Med, 6, pp.e33193~ (2016)
17. Diener HC, "The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study", Cephalalgia, 25, pp.776~787 (2005)
18. Goldstein J, "Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study", Headache, 46, pp.444~453 (2006)
19. Silberstein SD, "Migraine preventive medication reduces resource utilization", Headache, 43, pp.171~178 (2003)
20. Baratloo A, "Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache", Bangladesh J Pharmacol, 11, pp.428~432 (2016)
21. Baratloo A, "Intravenous caffeine for the treatment of acute migraine : a pilot study", J Caffeine Res, 5, pp.125~129 (2015)
22. Hawker GA, "Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)", Arthritis Care Res (Hoboken), 63(Suppl 11), pp.S240~S252 (2011)
23. Alschuler KN, "Defining mild, moderate, and severe pain in persons with multiple sclerosis", Pain Med, 13, pp.1358~1365 (2012)
24. Zelman DC, "Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy", Pain, 115, pp.29~36 (2005)
25. Kelly AM, "The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain", Emerg Med J, 18, pp.205~207 (2001)
26. Ray BS, "Experimental studies on headache:pain-sensitive structures of the head and their significance in headache", Arch Surg, 41, pp.813~856 (1940)
27. Silberstein SD, "Wolff’s headache and other head pain", pp.606~ (2001), Oxford University Press
28. Lance JW, "Mechanism and management of headache", pp.87~121 (2005), Elsevier Butterworth-Heinemann
29. Silberstein SD, "Headache in clinical practice", Isis Medical Media, pp.250~ (1998)
30. Ashina S, "Pathophysiology of migraine and tension-type headache", Tech Reg Anesth Pain Manag, 16, pp.14~18 (2012)
31. Pietrobon D, "Pathophysiology of migraine", Annu Rev Physiol, 75, pp.365~391 (2013)
32. Olesen J, "Timing and topography of cerebral blood flow, aura, and headache during migraine attacks", Ann Neurol, 28, pp.791~798 (1990)
33. Bolay H, "Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model", Nat Med, 8, pp.136~142 (2002)
34. Goadsby PJ, "Migraine--current understanding and treatment", N Engl J Med, 346, pp.257~270 (2002)
35. Tepper SJ, "Complementary and alternative treatments for childhood headaches", Curr Pain Headache Rep, 12, pp.379~383 (2008)
36. Taylor FR, "Nutraceuticals and headache : the biological basis", Headache, 51, pp.484~501 (2011)
37. Bhaskar S, "Recent progress in migraine pathophysiology : role of cortical spreading depression and magnetic resonance imaging", Eur J Neurosci, 38, pp.3540~3551 (2013)
38. Eikermann-Haerter K, "Cortical spreading depression and migraine", Curr Neurol Neurosci Rep, 10, pp.167~173 (2010)
39. D’Andrea G, "Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond", Neurol Sci, 31(Suppl 1), pp.S1~S7 (2010)
40. Levy D, "Migraine pain and nociceptor activation--where do we stand?", Headache, 50, pp.909~916 (2010)
41. Olesen J, "Origin of pain in migraine : evidence for peripheral sensitisation", Lancet Neurol, 8, pp.679~690 (2009)
42. Pietrobon D, "Neurobiology of migraine", Nat Rev Neurosci, 4, pp.386~398 (2003)
43. Dunwiddie TV, "The role and regulation of adenosine in the central nervous system", Annu Rev Neurosci, 24, pp.31~55 (2001)
44. Scher AI, "Risk factors for chronic daily headache", Curr Pain Headache Rep, 6, pp.486~491 (2002)
45. Tavares C, "Caffeine in the treatment of pain", Rev Bras Anestesiol, 62, pp.387~401 (2012)
46. Chiu HY, "Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials", Pain Physician, 19, pp.E97~E112 (2016)
47. Bolay H, "Gender influences headache characteristics with increasing age in migraine patients", Cephalalgia, 35, pp.792~800 (2015)
48. Vallerand AH, "The relationship of gender to pain", Pain Manag Nurs, 1, pp.8~15 (2000)
49. Fillingim RB, "Sex, gender, and pain: a review of recent clinical and experimental findings", J Pain, 10, pp.447~485 (2009)
50. Fillingim RB, "Sex, gender, and pain: women and men really are different", Curr Rev Pain, 4, pp.24~30 (2000)
51. Yezierski RP, "The effects of age on pain sensitivity: preclinical studies", Pain Med, 13(Suppl 2), pp.S27~S36 (2012)
52. El Tumi H, "Age-related changes in pain sensitivity in healthy humans:a systematic review with meta-analysis", Eur J Pain, 21, pp.955~964 (2017)
53. Victor TW, "Migraine prevalence by age and sex in the United States: a life-span study", Cephalalgia, 30, pp.1065~1072 (2010)
54. Harris AD, "The use and interpretation of quasi-experimental studies in medical informatics", J Am Med Inform Assoc, 13, pp.16~23 (2006)

관련 논문AI추천